Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

Ochoa, Eguzkine; Martin, José-Ezequiel; Assasi, Shervin; Beretta, Lorenzo; Carreira, Patricia; Guillén, Alfredo; Simeón, Carmen Pilar; Koumakis, Eugénie; Dieude, Philippe; Allanore, Yannick; García-Hernández, Francisco J; Espinosa, Gerard; Castellví, Ivan; Trapiella, Jose Luis; Rodriguez, Luis; González-Gay, Miguel Ángel; Egurbide, María Victoria; Sáez, Luis; Callejas-Rubio, Jose Luis; Vargas-Hitos, Jose Antonio; Hunzelmann, Nicolas; Riemekasten, Gabriela; Witte, Torsten; Distler, Jörg H W; Kreuter, Alexander; Lunardi, Claudio; Santaniello, Alessandro; Tan, Filemon K; Shiels, Paul G; Herrick, Ariane; Worthington, Jane; Vonk, Madelon C; Koeleman, Bobby P; Radstake, Timothy R D J; Mayes, Maureen D; Martin, Javier.
Clin Exp Rheumatol; 33(4 Suppl 91): S31-5, 2015 Jul-Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26314374